Patients with BAS-L bladder and breast tumours have worse outcome and a distinct response to therapy.36, 38, 39 To assess the impact of GATA6 loss on patient survival, we analysed a series of 58 patients from whom xenografts were established and transcriptome data were available. The gene discussed is GATA6; the disease is breast neoplasm.